Fractionated radioimmunotherapy with <sup>90</sup> Y‐clivatuzumab tetraxetan and low‐dose gemcitabine is active in advanced pancreatic cancer - Concepedia

Concepedia

Publication | Open Access

Fractionated radioimmunotherapy with <sup>90</sup> Y‐clivatuzumab tetraxetan and low‐dose gemcitabine is active in advanced pancreatic cancer

DOI Full Paper Access

84

Citations

22

References

2012

Year

Allyson J. Ocean, Kenneth Pennington, Michael J. Guarino, Arif Sheikh, Tanios Bekaii‐Saab, Aldo N. Serafini, Daniel Lee, Max W. Sung, Seza Güleç, Stanley J. Goldsmith,

Abstract

Fractionated radioimmunotherapy with (90) Y-hPAM4 and low-dose gemcitabine demonstrated promising therapeutic activity and manageable myelosuppression in patients with advanced pancreatic ductal carcinoma.

References

	Year	Citations

Page 1